Is Thymosin Alpha-1 Legal in Michigan?
HealthRX.com
Not FDA-approved in the US, and no Michigan-specific rule found
Key numbers
- 4 yes and 17 noFDA advisory committee vote on thymosin alpha-1 for the pharmacy bulks listSource: fda.gov, as cited Nov 8, 2026
- over 35 countriesNumber of countries where thymosin alpha-1 is approved, per an older review tied to its developerSource: pubmed.ncbi.nlm.nih.gov, as cited Nov 8, 2026
- 1.6 mgDose of Zadaxin, the finished injection sold outside the USSource: fda.gov, as cited Nov 8, 2026
At a glance
- FDA approval / None in the US; orphan drug designations are not approvals [1]
- Approved elsewhere / Italy, India and Hong Kong; Zadaxin 1.6 mg injection [1]
- State-licensed pharmacies / In none of FDA's three categories; the category 1 policy does not apply [3]
- Outsourcing facilities / Category 3, 'nominated without adequate support' [4]
- FDA advisory vote / 4 yes, 17 no on the free base and the acetate, December 2024 [5]
- Withdrawn nomination / FDA's concerns about immunogenicity and impurities remain posted [6]
- Sport / Not named on WADA's 2026 Prohibited List [7]
Is thymosin alpha-1 approved as a drug?
Not in the United States. There is no US marketing application for thymosin alpha-1, and its four US orphan drug designations come from a separate process that is not an approval [1].
It is approved as a medicine in some other countries. FDA's December 2024 review lists Italy, where Zadaxin is authorized as an adjuvant to influenza vaccination in immunocompromised people; India, for chronic hepatitis B in adults 18 or older with compensated liver disease and virus replication; and Hong Kong [1]. The European Medicines Agency holds only an orphan designation for hepatocellular carcinoma, not a marketing approval [1]. Two older reviews by authors tied to the Zadaxin developer put the count at 'over 35 countries' (2009) and 'more than 30 countries' (2007) [8][9].
Zadaxin is the finished 1.6 mg injection sold outside the US and is not interchangeable with bulk thymosin alpha-1 powder [1].
What people on Reddit report
Comments from an r/cfs thread about thymosin alpha-1 use. Some discuss its status abroad and in the US, and where people get it.
Thymosin alpha 1 is a prescription drug in many counties (one brand name is Zadaxin), there are many publications on its use and side effects and it has an excellent safety profile.Read the source discussion
However, it's use has been blocked by the FDA, so for many the only way to obtain it is via the grey "research only" market, where LPS testing is very rarely done.Read the source discussion
TA1, aka thymosin alpha 1, does not yet have FDA approval.Read the source discussion
Can a compounding pharmacy make thymosin alpha-1?
FDA's list for state-licensed pharmacies, updated May 14, 2026, has three categories. Thymosin alpha-1 is in none of them, so the category 1 policy — generally no action against compounders that meet its conditions — does not apply to it [3].
FDA proposed that the peptide not be added to the pharmacy bulks list. On December 4, 2024 its Pharmacy Compounding Advisory Committee voted 4 yes and 17 no, with no abstentions, on both the free base and the acetate; members who voted no cited no compelling evidence of clinical effectiveness and safety [5].
The peptide had been in category 2, for bulk substances that may present significant safety risks, and moved to the 'nominated but withdrawn' table after the nominators withdrew. FDA's page dated 04/22/2026 still posts its concerns: a significant risk of immunogenicity for certain routes of administration, peptide-impurity and characterization problems, and safety information it called inadequate to understand the extent of any safety issues [6].
Outsourcing facilities work from a separate list. On FDA's list for outsourcing facilities, updated March 21, 2025, thymosin alpha-1 is category 3, 'nominated without adequate support' [4]. HHS's October 2026 draft enforcement-discretion policy names six peptides — BPC-157, epitalon, KPV, MOTS-c, Semax and TB-500 — and thymosin alpha-1 is not among them [2].
Questions worth asking
Is it banned in sport?
WADA does not name thymosin alpha-1 on its 2026 Prohibited List [7]. WADA does name thymosin-beta-4 and its derivatives such as TB-500 in section S2.3 (growth factors), a different peptide. The S0 category covers substances with no approval from any governmental health authority, and thymosin alpha-1 is approved in some countries [7][1].
Check what you know
Question 1 of 4
Score: 0 right, 0 of 4 answered
Frequently asked questions
Is thymosin alpha-1 legal in Michigan?
Is thymosin alpha-1 FDA-approved?
Can a state-licensed compounding pharmacy make thymosin alpha-1?
Does WADA ban thymosin alpha-1?
References
Show all 10 referencesHide references
- U.S. Food and Drug Administration.
- Official web page.
- U.S. Food and Drug Administration.
- U.S. Food and Drug Administration.
- U.S. Food and Drug Administration.
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA.
- World Anti-Doping Agency.
- Goldstein AL, Goldstein AL. From lab to bedside: emerging clinical applications of thymosin alpha 1. Expert Opin Biol Ther. 2009;9(5):593-608.
- Tuthill C. Issues in pharmaceutical development of thymosin alpha1 from preclinical studies through marketing. Ann N Y Acad Sci. 2007;1112:351-6.
- Reddit participants. be careful about thymosin alpha-1 (r/cfs). Accessed 2026-11-11.